However, in other settings, such as PPARγ overexpression, cooperation with PPARGC1A increases AKT levels which in turn results in mitochondrial biogenesis that drives PRAD progression [97]. The gene discussed is PPARGC1A; the disease is prostate adenocarcinoma.